GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SkinBioTherapeutics PLC (LSE:SBTX) » Definitions » Total Long-Term Liabilities

SkinBioTherapeutics (LSE:SBTX) Total Long-Term Liabilities : £1.38 Mil (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is SkinBioTherapeutics Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. SkinBioTherapeutics's Total Long-Term Liabilities for the quarter that ended in Dec. 2024 was £1.38 Mil.


SkinBioTherapeutics Total Long-Term Liabilities Historical Data

The historical data trend for SkinBioTherapeutics's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SkinBioTherapeutics Total Long-Term Liabilities Chart

SkinBioTherapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only - 0.12 0.10 0.07 0.44

SkinBioTherapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.07 0.06 0.44 1.38

SkinBioTherapeutics Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.


SkinBioTherapeutics Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of SkinBioTherapeutics's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


SkinBioTherapeutics Business Description

Traded in Other Exchanges
Address
Bath Lane, The Core, Newcastle Helix, Newcastle upon Tyne, GBR, NE4 5TF
SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage, and restore skin utilizing proteins found in the human microbiota. It is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema.

SkinBioTherapeutics Headlines

From GuruFocus

ARS Pharmaceuticals Closes Merger with Silverback Therapeutics

By Value_Insider Value_Insider 11-08-2022

Silverback Therapeutics and ARS Pharmaceuticals Announce Merger

By Business Wire Business Wire 07-21-2022